Atlas Trials

Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mL

Clinical trial NCT04317625 · UNKNOWN

Trial details

NCT number
NCT04317625
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2020-04-01
Primary completion
2022-12-01
Enrollment
232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.